VC-backed Adaptive goes public

Seattle-based Adaptive, a biotech company, has raised $300 million for its IPO after pricing its 15 million shares at $20 per share. The stock began trading June 27, 2019 on the NASDAQ under the ticker symbol "ADPT." Goldman Sachs, J.P. Morgan and BofA Merrill Lynch are the lead underwriters. Adaptive's pre-IPO backers include Viking Global Matrix Capital Management Celgene, Foresite Capital and Alexandria Venture Investments.